XML 77 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Accumulated Other Comprehensive Income (Loss)
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss by component, net of related tax, were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2019
 
2018
 
2019
 
2018
 
Foreign currency translation adjustment
 
 
 
 
 
 
 
 
Balance at beginning of period
$
(144,899
)
 
$
(120,386
)
 
$
(141,255
)
 
$
(95,485
)
 
Other comprehensive income (loss) before reclassifications
(28,652
)
(1) 
(14,623
)
(1) 
(32,296
)
(1) 
(39,524
)
(1) 
Balance at end of period
$
(173,551
)
 
$
(135,009
)
 
$
(173,551
)
 
$
(135,009
)
 
Benefit plan liabilities
 
 
 
 
 
 
 
 
Balance at beginning of period
$
(105,935
)
 
$
(105,060
)
 
$
(104,375
)
 
$
(100,749
)
 
Other comprehensive income (loss) before reclassifications
1,634

(2) 
(6
)
(2) 
(714
)
(2) 
1,784

(2) 
Amounts reclassified from accumulated other comprehensive loss
612

(3) 
662

(4) 
1,400

(5) 
(5,439
)
(6) 
Balance at end of period
$
(103,689
)
 
$
(104,404
)
 
$
(103,689
)
 
$
(104,404
)
 
Fair value change of derivatives
 
 
 
 
 
 
 
 
Balance at beginning of period
$
1,623

 
$
(1,077
)
 
$
(458
)
 
$
(1,397
)
 
Other comprehensive income (loss) before reclassifications
(1,109
)
(7) 
1,736

(7) 
1,819

(7) 
2,638

(7) 
Amounts reclassified from accumulated other comprehensive loss
(449
)
(8) 
(255
)
(8) 
(1,296
)
(8) 
(837
)
(8) 
Balance at end of period
$
65

 
$
404

 
$
65

 
$
404

 
Accumulated other comprehensive loss, ending balance
$
(277,175
)
 
$
(239,009
)
 
$
(277,175
)
 
$
(239,009
)
 
(1)
Includes other comprehensive loss related to intra-entity foreign currency balances that are of a long-term investment nature of $10,785 and $473 for the three months ended September 30, 2019 and 2018, respectively, and $8,819 and $10,713 for the nine months ended September 30, 2019 and 2018, respectively.  
(2)
Net of tax (benefit) expense of $(76) and $(97) for the three months ended September 30, 2019 and 2018, respectively, and $(983) and $8,628 for the nine months ended September 30, 2019 and 2018, respectively. Includes other comprehensive loss of $3,224 for the nine months ended September 30, 2019 related to benefit plan liability remeasurement due to the divestiture of the Company’s AVS product line. See Note 4. “Divestiture.”
(3)
Includes the effect of the amortization of actuarial losses of $864, offset by the amortization of prior service credits of $39, net of tax of $213. See Note 14. “Pension and Postretirement Benefits Other Than Pensions.”
(4)
Includes the amortization of actuarial losses of $995, offset by prior service credits of $85, net of tax of $248. See Note 14. “Pension and Postretirement Benefits Other Than Pensions.”
(5)
Includes the effect of the amortization of actuarial losses of $2,607, offset by the amortization of prior service credits of $152, net settlement gain of $65 and curtailment gain of $204, net of tax of $786. The settlement and curtailment relate to the divestiture of the Company’s AVS product line. See Note 4. “Divestiture” and Note 14. “Pension and Postretirement Benefits Other Than Pensions.”
(6)
Includes the effect of the adoption of ASU 2018-02 of $8,569 and the amortization of prior service credits of $244, offset by curtailment loss of $1,123 and the amortization of actuarial losses of $2,981, net of tax of $730. See Note 14. “Pension and Postretirement Benefits Other Than Pensions.”
(7)
Net of tax (benefit) expense of $(258) and $517 for the three months ended September 30, 2019 and 2018, respectively, and $624 and $1,218 for the nine months ended September 30, 2019 and 2018, respectively. See Note 12. “Fair Value Measurements and Financial Instruments.”
(8)
Net of tax expense of $165 and $146 for the three months ended September 30, 2019 and 2018, respectively, and $470 and $280 for the nine months ended September 30, 2019 and 2018, respectively. Includes the effect of the adoption of ASU 2018-02 of $70 for the nine months ended September 30, 2018. See Note 12. “Fair Value Measurements and Financial Instruments.”